biotherapeutic

CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today…

SUNNYVALE, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. , today announced that it has entered into an agreement with BlueRock Therapeutics LP for the delivery of BlueRock’s cell therapy product candidates for the treatment…

The team administered eLBP to mice that were orally fed an ampicillin antibiotic. The team found that mice undergoing the biotherapeutic treatment had much lower levels of gut microbial loss and they also fully recovered…

London, April 06, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Live Biotherapeutic Products and Microbiome Manufacturing Market, 2022–2035” report to its list of offerings. Owing to the complex…